ArticleMedical oncology (Northwood, London, England)2025
Radiotherapy affects the ELAVL1-mediated autophagy pathway by promoting the release of LINC01943 exosomes in breast cancer cells to accelerate the M2 polarization of macrophages.
Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancer.Clinical and experimental medicine · 2026Review
- The link between macrophage polarization and response to radiotherapy in cancers: mechanisms and therapeutic opportunities.Frontiers in immunology · 2026Review
- Decoding the role of exosomes in bladder cancer: focusing on tumor progression and immune microenvironment modulation.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Radiotherapy (RT) resistance is a major obstacle in breast cancer (BC) treatment. Although the role of tumor-derived exosomal (Exo) lncRNAs in RT resistance and macrophage M2 polarization has been recognized, the mechanism by which Exo LINC01943 regulates macrophage polarization to influence BC RT resistance remains unclear. This study aimed to investigate the molecular mechanism by which RT regulates macrophage M2 polarization through BC cell-derived Exo LINC01943. An orthotopic xenograft tumor model was established by injecting MDA-MB-231 cells into nude mice, and experiments were conducted by co-culturing BC cell-derived Exo (from MDA-MB-231) with M0 macrophages. Exo were characterized using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). Macrophage polarization was assessed via RT-qPCR, flow cytometry, and ELISA. Autophagy was evaluated using immunofluorescence, Western blot, and MDC staining. The result shows that LINC01943 was highly expressed in BC and correlated with macrophage polarization. Further studies revealed that RT promoted the release of LINC01943 from MDA-MB-231-derived Exo. Under RT induction, Exo LINC01943 significantly upregulated M2 markers (CD206, IL-10, CD163, CCL22) and inflammatory factors (TGF-β1, IL-10) in macrophages, thereby promoting M2 polarization. Additionally, Exo LINC01943 increased p62 expression while reducing LC3-Ⅱ/Ⅰ and Beclin1 levels, suppressing autophagosome accumulation. Mechanistically, RT upregulated hnRNPA2B1 in MDA-MB-231 cells, stabilizing LINC01943 expression and facilitating its transfer to macrophages via Exo. In macrophages, overexpressed ELAVL1 promoted autophagy, and the autophagy activator Rapamycin reversed LINC01943-induced M2 polarization. Overall, this study found that RT upregulates hnRNPA2B1 to stabilize LINC01943 expression and enhance its Exo-mediated release, which subsequently inhibits ELAVL1-dependent autophagy in macrophages, accelerating M2 polarization.
Indexed as
Identifiers
41276711What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.